コンテンツへスキップ
Merck

スキップする

BPS60381

PDE9A2 Assay Kit

別名:

Assay Kits, PDE9A

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する
サイズ/SKU在庫状況単価

この商品について

UNSPSC Code:
41121811
現在、価格および在庫状況を閲覧できません。
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


manufacturer/tradename

BPS Bioscience

technique(s)

activity assay: suitable (Fluorescence Polarization)

UniProt accession no.

shipped in

dry ice

storage temp.

-65 to -96°C

General description

The PDE9A Assay Kit is designed for identification of PDE9A inhibitors using fluorescence polarization. The assay is based on the binding of a fluorescent nucleotide monophosphate generated by PDE9A to the binding agent. The key to the PDE9A Assay Kit is the specific binding agent. Using this kit, only two simple steps on a microtiter plate are required for PDE9A reactions. First, the fluorescently labeled cGMP is incubated with a sample containing PDE9A for 1 hour. Second, a binding agent is added to the reaction mix to produce a change in fluorescent polarization that can then be measured using a fluorescence reader.

Application

Study enzyme kinetics and screen small molecule inhibitors for drug discovery in high throughput screening (HTS) applications.
Phosphodiesterases (PDEs) play an important role in the dynamic regulation of the second messengers cAMP (cyclic adenosine monophosphate) and cGMP (cyclic guanosine monophosphate) signaling, by hydrolyzing them. The PDE superfamily is composed of 11 families, with PDE5 and PDE9 being cGMP-specific hydrolases, and thus regulating positive and negative responses to it. PDE9A2 is expressed in certain regions of the brain, where it plays a role in regulating synaptic transmission, learning, and memory. Its influence on cGMP levels can affect neuronal signaling. Since cGMP is a mediator in blood vessel relaxation, PDE9A2 has an impact on blood pressure regulation and overall vascular function.. Dysregulation of PDE9A2 may contribute to various conditions, including cardiovascular diseases, neurological disorders, and possibly cancer, as its activity influences cell signaling and growth. PDE9A2 is being explored as a target for drug development, particularly for neurological disorders like Alzheimer′s disease (AD), as modulating its activity can impact cognitive functions. Inhibiting PDE9A2 could increase cGMP levels, which may have beneficial effects in neurodegenerative diseases.
Datasheet and Protocols may be found here.

Features and Benefits

The PDE9A inhibitor screening assay kit comes in a convenient 96-well format, includingpurified PDE9A enzyme, fluorescently labeled PDE9 substrate (cGMP), binding agent,and PDE assay buffer for 100 enzyme reactions.


ピクトグラム

Corrosion

注意喚起語

Danger

ハザードコード

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

保管分類

8A - Combustible corrosive hazardous materials

WGK

WGK 2


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart

キットコンポーネントの情報を参照してください

jan



最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 資料 section.

サポートが必要な場合は、お問い合わせください カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする